(Q34702909)

4 August 2017

1 reference

title

Radiofrequency ablation of unresectable primary liver cancer (English)

1 reference

4 August 2017

Jerome Seidenfeld

1

1 reference

4 August 2017

Allan Korn

series ordinal

2

1 reference

4 August 2017

Naomi Aronson

series ordinal

3

1 reference

4 August 2017

publication date

1 June 2002

1 reference

Journal of the American College of Surgeons

4 August 2017

published in

1 reference

4 August 2017

volume

194

1 reference

4 August 2017

issue

6

1 reference

4 August 2017

page(s)

813-28; discussion 828

1 reference

Rising incidence of hepatocellular carcinoma in the United States

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901180-8

7 January 2021

Cancer statistics, 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901180-8

7 January 2021

Surgical treatment of malignant liver tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901180-8

7 January 2021

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901180-8

7 January 2021

Hepatocellular carcinoma. A concise guide to its status and management

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901180-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901180-8

1 reference

7 January 2021

Minimally invasive treatment of malignant hepatic tumors: at the threshold of a major breakthrough

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901180-8

7 January 2021

Local ablation therapy for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901180-8

7 January 2021

Radiofrequency thermal ablation of liver tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901180-8

7 January 2021

Management of hepatic metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901180-8

7 January 2021

New trends in the surgical treatment of colorectal cancer liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901180-8

7 January 2021

Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901180-8

7 January 2021

Cryosurgical ablation and radiofrequency ablation for unresectable hepatic malignant neoplasms: a proposed algorithm

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901180-8

7 January 2021

Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901180-8

7 January 2021

Clinical short-term results of radiofrequency ablation in primary and secondary liver tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901180-8

7 January 2021

Ultrasound-guided percutaneous treatment of hepatocellular carcinoma by radiofrequency hyperthermia with a 'cooled-tip needle'. A preliminary clinical experience.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901180-8

7 January 2021

Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901180-8

7 January 2021

Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901180-8

7 January 2021

Percutaneous radiofrequency interstitial thermal ablation of small hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901180-8

7 January 2021

Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901180-8

7 January 2021

Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901180-8

7 January 2021

Percutaneous radiofrequency thermal ablation combined with transcatheter arterial embolization in the treatment of large hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901180-8

7 January 2021

Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901180-8

7 January 2021

Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901180-8

7 January 2021

Tumor size determines the efficacy of percutaneous ethanol injection for the treatment of small hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901180-8

7 January 2021

Percutaneous ethanol injection for the treatment of small hepatocellular carcinoma. Study of 95 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901180-8

7 January 2021

Risk factors for intrahepatic recurrence of hepatocellular carcinoma in cirrhotic patients treated by percutaneous ethanol injection.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901180-8

7 January 2021

Predictive factors of survival and intrahepatic recurrence of hepatocellular carcinoma in cirrhosis after percutaneous ethanol injection: analysis of 71 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901180-8

7 January 2021

Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901180-8

7 January 2021

Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901180-8

7 January 2021

Treatment of unresectable primary liver cancer with intrahepatic fluorodeoxyuridine and mitomycin C through an implantable pump

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901180-8

7 January 2021

Arterial infusion chemotherapy for advanced hepatocellular carcinoma using EPF and EAP therapies

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901180-8

7 January 2021

Hepatic arterial infusion of floxuridine, leucovorin, doxorubicin, and cisplatin for hepatocellular carcinoma: effects of hepatitis B and C viral infection on drug toxicity and patient survival

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901180-8

7 January 2021

A randomized prospective trial comparing full dose chemotherapy to 131I antiferritin: An RTOG study

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901180-8

7 January 2021

Low serum alpha-fetoprotein level in patients with hepatocellular carcinoma as a predictor of response to 5-FU and interferon-alpha-2b

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901180-8

7 January 2021

Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis. A study in 22 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901180-8

7 January 2021

10.1016/S1072-7515(02)01180-8

Identifiers

DOI

1 reference

4 August 2017

1 reference